"Oligos" are already hard at work in both mature and emerging market segments. The possibilities and market growth are unlimited. The analysis shows that investors do not yet understand the scope of ...

A live webcast of the presentation can be accessed on the “Events & Presentations” page in the Investor section of Korro’s website at www.korrobio.com. Following the presentation, a replay of the ...

Analyst Mayank Mamtani from B.Riley Financial reiterated a Buy rating on Denali Therapeutics (DNLI – Research Report) and keeping the price ...